153 related articles for article (PubMed ID: 28322107)
1. Surface modulation of polymeric nanocarriers enhances the stability and delivery of proteins and small molecules.
Amoozgar Z; Goldberg MS
Nanomedicine (Lond); 2017 Apr; 12(7):729-743. PubMed ID: 28322107
[TBL] [Abstract][Full Text] [Related]
2. Surface modification of doxorubicin-loaded nanoparticles based on polydopamine with pH-sensitive property for tumor targeting therapy.
Bi D; Zhao L; Yu R; Li H; Guo Y; Wang X; Han M
Drug Deliv; 2018 Nov; 25(1):564-575. PubMed ID: 29457518
[TBL] [Abstract][Full Text] [Related]
3. Prevention of Oxidized Low Density Lipoprotein-Induced Endothelial Cell Injury by DA-PLGA-PEG-cRGD Nanoparticles Combined with Ultrasound.
Li Z; Huang H; Huang L; Du L; Sun Y; Duan Y
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28406431
[TBL] [Abstract][Full Text] [Related]
4. Low-molecular-weight protamine-modified PLGA nanoparticles for overcoming drug-resistant breast cancer.
Wang H; Zhao Y; Wang H; Gong J; He H; Shin MC; Yang VC; Huang Y
J Control Release; 2014 Oct; 192():47-56. PubMed ID: 25003794
[TBL] [Abstract][Full Text] [Related]
5. Doxorubicin-loaded star-shaped copolymer PLGA-vitamin E TPGS nanoparticles for lung cancer therapy.
Zhang J; Tao W; Chen Y; Chang D; Wang T; Zhang X; Mei L; Zeng X; Huang L
J Mater Sci Mater Med; 2015 Apr; 26(4):165. PubMed ID: 25791459
[TBL] [Abstract][Full Text] [Related]
6. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
Feng SS; Mei L; Anitha P; Gan CW; Zhou W
Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
[TBL] [Abstract][Full Text] [Related]
7. In vitro study of anticancer drug doxorubicin in PLGA-based microparticles.
Lin R; Shi Ng L; Wang CH
Biomaterials; 2005 Jul; 26(21):4476-85. PubMed ID: 15701377
[TBL] [Abstract][Full Text] [Related]
8. Dual targeted polymeric nanoparticles based on tumor endothelium and tumor cells for enhanced antitumor drug delivery.
Gupta M; Chashoo G; Sharma PR; Saxena AK; Gupta PN; Agrawal GP; Vyas SP
Mol Pharm; 2014 Mar; 11(3):697-715. PubMed ID: 24512060
[TBL] [Abstract][Full Text] [Related]
9. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin.
Yadav AK; Mishra P; Mishra AK; Mishra P; Jain S; Agrawal GP
Nanomedicine; 2007 Dec; 3(4):246-57. PubMed ID: 18068091
[TBL] [Abstract][Full Text] [Related]
10. Docetaxel-Loaded PLGA Nanoparticles Improve Efficacy in Taxane-Resistant Triple-Negative Breast Cancer.
Bowerman CJ; Byrne JD; Chu KS; Schorzman AN; Keeler AW; Sherwood CA; Perry JL; Luft JC; Darr DB; Deal AM; Napier ME; Zamboni WC; Sharpless NE; Perou CM; DeSimone JM
Nano Lett; 2017 Jan; 17(1):242-248. PubMed ID: 27966988
[TBL] [Abstract][Full Text] [Related]
11. Targeted hepatocellular carcinoma therapy: transferrin modified, self-assembled polymeric nanomedicine for co-delivery of cisplatin and doxorubicin.
Zhang X; Li J; Yan M
Drug Dev Ind Pharm; 2016 Oct; 42(10):1590-9. PubMed ID: 26942448
[TBL] [Abstract][Full Text] [Related]
12. Brain-targeted delivery of doxorubicin using glutathione-coated nanoparticles for brain cancers.
Geldenhuys W; Wehrung D; Groshev A; Hirani A; Sutariya V
Pharm Dev Technol; 2015 Jun; 20(4):497-506. PubMed ID: 24597667
[TBL] [Abstract][Full Text] [Related]
13. Long circulating chitosan/PEG blended PLGA nanoparticle for tumor drug delivery.
Parveen S; Sahoo SK
Eur J Pharmacol; 2011 Nov; 670(2-3):372-83. PubMed ID: 21951969
[TBL] [Abstract][Full Text] [Related]
14. Biodegradable nanoparticles containing doxorubicin-PLGA conjugate for sustained release.
Yoo HS; Oh JE; Lee KH; Park TG
Pharm Res; 1999 Jul; 16(7):1114-8. PubMed ID: 10450940
[TBL] [Abstract][Full Text] [Related]
15. "Triple-punch" strategy for triple negative breast cancer therapy with minimized drug dosage and improved antitumor efficacy.
Su S; Tian Y; Li Y; Ding Y; Ji T; Wu M; Wu Y; Nie G
ACS Nano; 2015 Feb; 9(2):1367-78. PubMed ID: 25611071
[TBL] [Abstract][Full Text] [Related]
16. Efficient delivery of antitumor drug to the nuclei of tumor cells by amphiphilic biodegradable poly(L-aspartic acid-co-lactic acid)/DPPE co-polymer nanoparticles.
Han S; Liu Y; Nie X; Xu Q; Jiao F; Li W; Zhao Y; Wu Y; Chen C
Small; 2012 May; 8(10):1596-606. PubMed ID: 22411637
[TBL] [Abstract][Full Text] [Related]
17. Pathogen-Mimicking Polymeric Nanoparticles based on Dopamine Polymerization as Vaccines Adjuvants Induce Robust Humoral and Cellular Immune Responses.
Liu Q; Jia J; Yang T; Fan Q; Wang L; Ma G
Small; 2016 Apr; 12(13):1744-57. PubMed ID: 26849717
[TBL] [Abstract][Full Text] [Related]
18. Ultrafine PEG-coated poly(lactic-co-glycolic acid) nanoparticles formulated by hydrophobic surfactant-assisted one-pot synthesis for biomedical applications.
Chu CH; Wang YC; Huang HY; Wu LC; Yang CS
Nanotechnology; 2011 May; 22(18):185601. PubMed ID: 21415469
[TBL] [Abstract][Full Text] [Related]
19. Hyaluronic acid-decorated poly(lactic-co-glycolic acid) nanoparticles for combined delivery of docetaxel and tanespimycin.
Pradhan R; Ramasamy T; Choi JY; Kim JH; Poudel BK; Tak JW; Nukolova N; Choi HG; Yong CS; Kim JO
Carbohydr Polym; 2015 Jun; 123():313-23. PubMed ID: 25843864
[TBL] [Abstract][Full Text] [Related]
20. Formulation and optimization of doxorubicin loaded polymeric nanoparticles using Box-Behnken design: ex-vivo stability and in-vitro activity.
Shaikh MV; Kala M; Nivsarkar M
Eur J Pharm Sci; 2017 Mar; 100():262-272. PubMed ID: 28126560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]